CHICAGO - THE common diabetes drug metformin may hold promise as a way to keep smokers from developing lung cancer, US researchers said on Wednesday. They said metformin prevented lung tumour growth in mice exposed to a cancer-causing agent found in tobacco smoke, and because it is already widely used in people, it may be worth further study.
GARDNER -- Dr. David M. Harlan, a leading figure in diabetes care and clinical research, will be the featured presenter at the annual Heywood Hospital Diabetes Education Fair to be held at Mount Wachusett Community College on Sept.
Metformin reduced the development of lung tumors in mice by more than 70%. Clinical trials on humans for lung, breast and prostate cancer are being organized. A growing body of evidence suggests that the widely used diabetes drug metformin can reduce the risk of cancer, researchers said Wednesday.
Diabetes is the focus of a U.S. researcher who says mothers who don't breastfeed their children may be more likely to develop type 2 diabetes, than mothers who do breastfeed. Study co-author Dr. Eleanor Bimla Schwarz at the University of Pittsburgh says diet and exercise are widely known to affect the risk of type 2 diabetes but few people realize breastfeeding also reduces mothers' risk of ...